Quentec Asset Management Llc decreased Himax Technologies Inc (HIMX) stake by 43.46% reported in 2017Q4 SEC filing. Quentec Asset Management Llc sold 1.16M shares as Himax Technologies Inc (HIMX)’s stock declined 34.70%. The Quentec Asset Management Llc holds 1.51M shares with $15.71 million value, down from 2.67M last quarter. Himax Technologies Inc now has $1.21 billion valuation. The stock decreased 2.69% or $0.2 during the last trading session, reaching $7.05. About 1.11M shares traded. Himax Technologies, Inc. (NASDAQ:HIMX) has declined 30.83% since April 24, 2017 and is downtrending. It has underperformed by 42.38% the S&P500.
INTELGENX TECHNOLOGIES CORP (OTCMKTS:IGXT) had a decrease of 67.06% in short interest. IGXT’s SI was 5,600 shares in April as released by FINRA. Its down 67.06% from 17,000 shares previously. The SI to INTELGENX TECHNOLOGIES CORP’s float is 0.01%. The stock increased 3.13% or $0.02 during the last trading session, reaching $0.66. About 24,296 shares traded. IntelGenx Technologies Corp. (OTCMKTS:IGXT) has 0.00% since April 24, 2017 and is . It has underperformed by 11.55% the S&P500.
Among 12 analysts covering Himax Tech (NASDAQ:HIMX), 5 have Buy rating, 2 Sell and 5 Hold. Therefore 42% are positive. Himax Tech had 55 analyst reports since August 10, 2015 according to SRatingsIntel. Craig Hallum downgraded Himax Technologies, Inc. (NASDAQ:HIMX) on Tuesday, January 10 to “Hold” rating. The rating was downgraded by Roth Capital to “Neutral” on Thursday, March 15. As per Friday, October 20, the company rating was maintained by Robert W. Baird. The firm has “Buy” rating given on Wednesday, November 29 by Roth Capital. The firm has “Buy” rating given on Friday, August 4 by Robert W. Baird. The firm earned “Sell” rating on Friday, August 4 by Oppenheimer. On Wednesday, August 30 the stock rating was maintained by Roth Capital with “Buy”. Roth Capital initiated it with “Buy” rating and $10 target in Thursday, September 29 report. The company was upgraded on Thursday, September 28 by Lake Street. Northland Capital maintained it with “Buy” rating and $1200 target in Thursday, August 3 report.
Analysts await Himax Technologies, Inc. (NASDAQ:HIMX) to report earnings on May, 10. They expect $-0.03 earnings per share, down 400.00% or $0.04 from last year’s $0.01 per share. After $0.14 actual earnings per share reported by Himax Technologies, Inc. for the previous quarter, Wall Street now forecasts -121.43% negative EPS growth.
IntelGenx Technologies Corp., a drug delivery company, develops novel oral immediate-release and controlled-release products for the pharmaceutical market. The company has market cap of $44.70 million. It offers RIZAPORT, an oral thin film formulation of rizatriptan benzoate for the treatment of acute migraines. It currently has negative earnings. The companyÂ’s products under development comprise INT0001/2004, an anti-hypertension drug; INT0004/2006, an antidepressant; INT0007/2006 for the treatment of erectile dysfunction; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid dependence; INT0036/2012 for schizophrenia; and INT0043/2015 to treat mild cognitive impairment and AlzheimerÂ’s disease.